{"id":"https://openalex.org/W1992932410","doi":"https://doi.org/10.1007/s11095-015-1633-2","title":"Evaluation of Targets for Maytansinoid ADC Therapy Using a Novel Radiochemical Assay","display_name":"Evaluation of Targets for Maytansinoid ADC Therapy Using a Novel Radiochemical Assay","publication_year":2015,"publication_date":"2015-01-28","ids":{"openalex":"https://openalex.org/W1992932410","doi":"https://doi.org/10.1007/s11095-015-1633-2","mag":"1992932410","pmid":"https://pubmed.ncbi.nlm.nih.gov/25630819"},"language":"en","primary_location":{"id":"doi:10.1007/s11095-015-1633-2","doi":"https://doi.org/10.1007/s11095-015-1633-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-015-1633-2","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086428809","display_name":"Katharine C. Lai","orcid":"https://orcid.org/0000-0003-4842-8041","observed_orcids":["https://orcid.org/0000-0003-4842-8041"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Katharine C. Lai","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA. Kate.Lai@immunogen.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA. Kate.Lai@immunogen.com","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052641459","display_name":"Jutta Deckert","orcid":"https://orcid.org/0009-0005-2770-3560","observed_orcids":["https://orcid.org/0009-0005-2770-3560"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jutta Deckert","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038716576","display_name":"Yulius Y. Setiady","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yulius Y. Setiady","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000835489","display_name":"Prerak Shah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Prerak Shah","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101938134","display_name":"Lintao Wang","orcid":"https://orcid.org/0000-0003-2794-7387","observed_orcids":["https://orcid.org/0000-0003-2794-7387"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lintao Wang","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112381046","display_name":"Ravi V. J. Chari","orcid":"https://orcid.org/0000-0002-2373-5435","observed_orcids":["https://orcid.org/0000-0002-2373-5435"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Chari","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210096123"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036231578","display_name":"John M. Lambert","orcid":"https://orcid.org/0000-0001-7159-2195","observed_orcids":["https://orcid.org/0000-0001-7159-2195"]},"institutions":[{"id":"https://openalex.org/I4210096123","display_name":"ImmunoGen (United States)","ror":"https://ror.org/00scb2f23","country_code":"US","type":"company","lineage":["https://openalex.org/I4210096123"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John M. Lambert","raw_affiliation_strings":["ImmunoGen, Inc., Waltham, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ImmunoGen, Inc., Waltham, Massachusetts, USA","institution_ids":["https://openalex.org/I4210096123"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5086428809"],"corresponding_institution_ids":["https://openalex.org/I4210096123"],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":1.0827,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.73521812,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"32","issue":"11","first_page":"3593","last_page":"3603"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6996999979019165,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.6996999979019165,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.2362000048160553,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","score":0.032499998807907104,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9980000257492065},{"id":"https://openalex.org/keywords/maytansinoids","display_name":"maytansinoids","score":0.7839999794960022},{"id":"https://openalex.org/keywords/internalization","display_name":"internalization","score":0.6019999980926514},{"id":"https://openalex.org/keywords/radiochemical-assay","display_name":"radiochemical assay","score":0.7080000042915344},{"id":"https://openalex.org/keywords/egfr","display_name":"EGFR","score":0.8059999942779541},{"id":"https://openalex.org/keywords/small-cell-lung-cancer","display_name":"small cell lung cancer","score":0.7049999833106995},{"id":"https://openalex.org/keywords/b-cell-lymphoma","display_name":"B-cell lymphoma","score":0.8240000009536743},{"id":"https://openalex.org/keywords/cd19","display_name":"CD19","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cd20","display_name":"CD20","score":0.9860000014305115},{"id":"https://openalex.org/keywords/cd22","display_name":"CD22","score":0.9929999709129333},{"id":"https://openalex.org/keywords/cd37","display_name":"CD37","score":0.9150000214576721},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.656000018119812}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6996076703071594},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6220217347145081},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5915958285331726},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.564361572265625},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.5437033176422119},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5271826982498169},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5259186029434204},{"id":"https://openalex.org/C197336794","wikidata":"https://www.wikidata.org/wiki/Q5161150","display_name":"Conjugate","level":2,"score":0.45899584889411926},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.41662395000457764},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.39998283982276917},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3574369549751282},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2335260510444641},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18440264463424683},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.17825216054916382},{"id":"https://openalex.org/C134306372","wikidata":"https://www.wikidata.org/wiki/Q7754","display_name":"Mathematical analysis","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008453","descriptor_name":"Maytansine","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D011869","descriptor_name":"Radioligand Assay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014316","descriptor_name":"Tritium","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018796","descriptor_name":"Immunoconjugates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058990","descriptor_name":"Molecular Targeted Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s11095-015-1633-2","doi":"https://doi.org/10.1007/s11095-015-1633-2","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s11095-015-1633-2","pdf_url":null,"source":{"id":"https://openalex.org/S103865650","display_name":"Pharmaceutical Research","issn_l":"0724-8741","issn":["0724-8741","1573-904X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Research","raw_type":"journal-article"},{"id":"pmid:25630819","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25630819","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1790387644","https://openalex.org/W1795111525","https://openalex.org/W1959625971","https://openalex.org/W1971738718","https://openalex.org/W1990310737","https://openalex.org/W1996362579","https://openalex.org/W2000568282","https://openalex.org/W2004783782","https://openalex.org/W2010566371","https://openalex.org/W2023807748","https://openalex.org/W2049518174","https://openalex.org/W2060756717","https://openalex.org/W2065528643","https://openalex.org/W2078386415","https://openalex.org/W2083709832","https://openalex.org/W2104182248","https://openalex.org/W2132895530","https://openalex.org/W2143891754","https://openalex.org/W2164231501","https://openalex.org/W2165168809","https://openalex.org/W2169000897","https://openalex.org/W2324366850","https://openalex.org/W2468934354"],"related_works":["https://openalex.org/W2030196691","https://openalex.org/W2404063586","https://openalex.org/W2463348911","https://openalex.org/W1971738718","https://openalex.org/W1983908584","https://openalex.org/W2284191808","https://openalex.org/W2007756994","https://openalex.org/W7223065116","https://openalex.org/W2287661813","https://openalex.org/W2339482712"],"abstract_inverted_index":null,"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}